Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 934
Filtrar
1.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab
Artigo em Inglês | IBECS | ID: ibc-194191

RESUMO

OBJECTIVE: Entrustable Professional Activities (EPAs) are a list of professional tasks (with associated competency ratings) that pharmacy educational organizations support, and accreditation organizations require, for assessment by colleges and schools of pharmacy. This manuscript assesses the perceived frequency of performing EPAs in the population health promoter (PHP) domain among pharmacists practicing in North Dakota. METHODS: This survey assessed the self-reported EPA activities (inclusive of the PHP domain) of registered pharmacists living and practicing in North Dakota. There were 990 pharmacists surveyed, and 457 (46.1%) of pharmacists responded. RESULTS: Within the PHP domain, pharmacists reported performing "Minimize adverse drug events and medication errors" most frequently (mean=3.4, SD=2.0), followed by "Ensure that patients have been immunized against vaccine-preventable diseases" (mean=2.3, SD 2.3), "Maximize the appropriate use of medications in a population" (mean=2.2, SD 2.3), and "Identify patients at risk for prevalent diseases in a population" (mean=1.3, SD=1.9). In these Core EPAs PHP domains, the clinical pharmacists reported the highest level, followed by pharmacy managers and staff pharmacists. CONCLUSION: Pharmacists in North Dakota reported that EPAs in the PHP domain are practiced regularly. Thus, EPAs in the PHP domain have potential as a means to assess outcomes in pharmacy education and practice


No disponible


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Avaliação Educacional/métodos , Educação em Farmácia , Assistência Farmacêutica/normas , Promoção da Saúde/métodos , Estados Unidos , Educação Baseada em Competências , Internato não Médico/métodos , Erros de Medicação/prevenção & controle
2.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab
Artigo em Inglês | IBECS | ID: ibc-194192

RESUMO

The central role of the Portuguese National Health Service (P-NHS) guarantees virtually free universal coverage. Key policy papers, such as the National Health Plan and the National Plan for Patient Safety have implications for pharmacists, including an engagement in medicines reconciliation. These primary health care reform, while not explicitly contemplating a role for pharmacists, offer opportunities for the involvement of primary care pharmacists in medicines management. Primary care pharmacists, who as employees of the P-NHS work closely with an interdisciplinary team, have launched a pilot service to manage polypharmacy in people living with multimorbidities, involving potential referral to community pharmacy. Full integration of community pharmacy into primary health care is challenging due to their nature as private providers, which implies the need for the recognition that public and private health sectors are mutually complementary and may maximize universal health coverage. The scope of practice of community pharmacies has been shifting to service provision, currently supported by law and in some cases, including the needle and syringe exchange program and generic substitution, remunerated. Key changes envisaged for the future of pharmacists and their integration in primary care comprise the development and establishment of clinical pharmacy as a specialization area, peer clinician recognition and better integration in primary care teams, including full access to clinical records. These key changes would enable pharmacists to apply their competence in medicines optimization for improved patient outcomes


No disponible


Assuntos
Humanos , Atenção Primária à Saúde/normas , Política de Saúde , Farmácias/normas , Farmacêuticos/normas , Assistência Farmacêutica/normas , Farmácias/organização & administração , Portugal , Assistência Farmacêutica/organização & administração , Prática Profissional , Papel Profissional
3.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-194195

RESUMO

BACKGROUND: Antibiotics are the most frequently used medicines worldwide with most of the countries defining these as prescription-only medicines. Though, dispensing non-prescribed antibiotics represent one of the chief causal factors to the irrational use of antibiotics that paves the way to the development of antimicrobial resistance. OBJECTIVE: We aimed at describing the practices and the enablers for non-prescribed antibiotic dispensing in Maputo city, Mozambique. METHODS: A qualitative study was conducted, between October 2018 and March 2019, in nine private pharmacies randomly selected across Maputo city. Eighteen pharmacists were contacted and seventeen enrolled through snowball sampling. In-depth interviews were conducted, audiotaped, and transcribed verbatim. Transcripts were coded and analysed though thematic analysis with guidelines from Braun and Clark. The Consolidated Criteria for Reporting Qualitative Studies (COREQ) checklist by (Tong, 2007) was performed. RESULTS: Out of seventeen, fifteen pharmacists admitted non-prescribed dispensing of antibiotics. Common antibiotic dispensing practices included; dispensing without prescription, without asking for a brief clinical history of patients, without clear explanation of the appropriate way of administering, without advising on the side effects. Reasons for non-prescribed antibiotic dispensing are linked to patients' behaviour of demanding for non-prescribed antibiotics, to the patients expectations and beliefs on the healing power of antibiotics, to the physicians' prescribing practices. Other reasons included the pressure for profits from the pharmacy owners, the fragile law enforcement, and absence of accountability mechanisms. CONCLUSIONS: The practices of non-prescribed antibiotic dispensing characterize the 'daily life' of the pharmacists. On the one hand, the patient's demand for antibiotics without valid prescriptions, and pharmacist's wish to assist based on their role in the pharmacy, the pressure for profits and on the understanding of the larger forces driving the practices of self-medication with antibiotics - rock. On the other hand, pharmacists are aware of the legal status of antibiotics and the public health consequences of their inappropriate dispensing practices and their professional and ethical responsibility for upholding the law - hard place. Highlighting the role of pharmacists and their skills as health promotion professionals is needed to optimizing antibiotic dispensing and better conservancy in Mozambique


No disponible


Assuntos
Humanos , Masculino , Feminino , Adulto , Prática Profissional , Medicamentos sem Prescrição/normas , Antibacterianos/uso terapêutico , Medicamentos de Venda Assistida/normas , Boas Práticas de Dispensação , Moçambique , Assistência Farmacêutica/normas , Saúde Pública
4.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. graf
Artigo em Inglês | IBECS | ID: ibc-194196

RESUMO

BACKGROUND: Type 2 diabetes mellitus is a chronic disease that is reaching epidemic proportions worldwide. It is imperative to adopt an integrated strategy, which involves a close collaboration between the patient and a multidisciplinary team of which pharmacists should be integral elements. OBJECTIVE: This work aims to identify and summarize the main effects of interventions carried out by clinical pharmacists in the management of patients with type 2 diabetes, considering clinical, humanistic and economic outcomes. METHODS: PubMed and Cochrane Central Register of Controlled Trials were searched for randomized controlled trials assessing the effectiveness of such interventions compared with usual care that took place in hospitals or outpatient facilities. RESULTS: This review included 39 studies, involving a total of 5,474 participants. Beneficial effects were observed on various clinical outcomes such as glycemia, blood pressure, lipid profile, body mass index and coronary heart disease risk. For the following parameters, the range for the difference in change from baseline to final follow-up between the intervention and control groups was: HbA1c, -0.05% to -2.1%; systolic blood pressure, +3.45 mmHg to -10.6 mmHg; total cholesterol, +10.06 mg/dL to -32.48 mg/dL; body mass index, +0.6 kg/m2 to -1.94 kg/m2; and coronary heart disease risk, -3.0% and -12.0% (among the studies that used Framinghan prediction method). The effect on medication adherence and health-related quality of life was also positive. In the studies that performed an economic evaluation, the interventions proved to be economically viable. CONCLUSIONS: These findings support and encourage the integration of clinical pharmacists into multidisciplinary teams, underlining their role in improving the management of type 2 diabetes


No disponible


Assuntos
Humanos , Farmacêuticos/normas , Diabetes Mellitus Tipo 2/tratamento farmacológico , Competência Clínica , Assistência Farmacêutica/normas , Assistência Farmacêutica/organização & administração , Cooperação e Adesão ao Tratamento , Custos e Análise de Custo/métodos , Hemoglobina A Glicada/uso terapêutico , Qualidade de Vida
5.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-194197

RESUMO

BACKGROUND: While pharmacists are well positioned to implement pharmacogenomic testing in healthcare systems, uptake has been limited. OBJECTIVE: The primary objective of this survey was to determine how post-graduate education and training influences pharmacist's knowledge and attitudes of pharmacogenomic testing. METHODS: Survey questions were developed by the study team, and responses were collected electronically using REDCapTM. The electronic survey was sent to all pharmacists (n=161) within a large, multi-state healthcare system by email. RESULTS: A total of 75 (47%) respondents completed all aspects of the survey. The majority of respondents were female (60%), worked in acute care settings (57%), were full-time employees (80%), and worked in an urban area (85%), with many graduating in or after 2010 (43%). For post-graduate education, 36% of respondents completed a Post-Graduate Year One Residency (PGY-1), and 27% had a board certification. Those that completed a PGY-1 residency were significantly more likely to have received formal training or education on pharmacogenomics than those who had not. They also assessed their own knowledge of pharmacogenomic resources and guidelines higher than those without PGY-1 training. More recent graduates were also significantly more likely to have received formal training or education on pharmacogenomics. Additionally, pharmacists who completed a PGY-1 residency were more likely to respond favorably to pharmacogenomics being offered through pharmacy services. Pharmacists with board certification were more comfortable interpreting results of a pharmacogenomic test than those without board certification. CONCLUSIONS: Pharmacists who have completed a PGY-1 residency or received board certification appear more comfortable with interpretation and implementation of pharmacogenomic testing


No disponible


Assuntos
Humanos , Masculino , Feminino , Testes Farmacogenômicos/tendências , Conhecimentos, Atitudes e Prática em Saúde , Farmacogenética/educação , Assistência Farmacêutica/normas , Atitude do Pessoal de Saúde , Assistência Farmacêutica/organização & administração , Inquéritos e Questionários , Análise de Dados
6.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-194203

RESUMO

The United States (US) has a complex healthcare system with a mix of public, private, nonprofit, and for-profit insurers, healthcare institutions and organizations, and providers. Unlike other developed countries, there is not a single payer healthcare system or a national pharmaceutical benefits scheme/plan. Despite spending over USD 10,000 per capita in healthcare, the US is among the worst performers compared to other developed countries in outcomes including life expectancy at birth, infant mortality, safety during childbirth, and unmanaged chronic conditions (e.g., asthma, diabetes). Primary care is delivered by physicians and advanced practice providers (i.e., nurse practitioners and physician assistants) in a variety of settings including large health systems, federally qualified health centers or free clinics that provide care to the underserved, or specific facilities for veterans or American Indian and Alaska native peoples. Since 2010, primary care delivery has shifted toward providing patient-centered, coordinated, comprehensive care focused on providing proactive, rather than reactive, population health management, and on the quality, versus volume, of care. Community pharmacy comprises a mix of independently owned, chain, supermarket and mass merchant pharmacies. Community pharmacies provide services such as immunizations, medication therapy management, medication packaging, medication synchronization, point-of-care testing and, in specific states where legislation has been passed, hormonal contraception, opioid reversal agents, and smoking cessation services. There has been criticism regarding the lack of standard terminology for services such as medication synchronization and medication therapy management, their components and how they should be provided, which hampers comparability across studies. One of the main challenges for pharmacists in the US is the lack of provider status at the federal level. This means that pharmacists are not allowed to use existing fee-for-service health insurance billing codes to receive reimbursement for non-dispensing services. In addition, despite there being regulatory infrastructure in multiple states, the extent of service implementation is either low or unknown. Research found that pharmacists face numerous barriers when providing some of these services. State fragmentation and the lack of a single pharmacy organization and vision for the profession are additional challenges


No disponible


Assuntos
Humanos , Atenção Primária à Saúde , Farmácias/normas , Farmacêuticos/normas , Prática Profissional , Assistência Farmacêutica/normas , Farmácias/organização & administração , Estados Unidos
7.
Pharm. pract. (Granada, Internet) ; 18(3): 0-0, jul.-sept. 2020. tab
Artigo em Inglês | IBECS | ID: ibc-194204

RESUMO

With a primary care physician shortage, utilization of pharmacists in the ambulatory care setting has proven to have positive economic and clinical outcomes for the practice and for patients. To extend the reach of the pharmacists, students may assist with patient care activities, such as medication reconciliation, point-of-care testing, and counseling. Evidence has shown that students benefit in building confidence, as well as improved perceptions of interprofessional care, while positive patient outcomes are maintained. There are many methods for schools to integrate these experiences early into their curriculum, as well as for students to explore opportunities on their own


No disponible


Assuntos
Humanos , Estudantes de Farmácia/estatística & dados numéricos , Educação em Farmácia/métodos , Papel Profissional , Assistência Ambulatorial , Assistência Farmacêutica/organização & administração , Assistência Farmacêutica/normas
8.
BMC Health Serv Res ; 20(1): 487, 2020 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-32487066

RESUMO

BACKGROUND: Hospital clinical pharmacists have been working in many countries for many years and clinical pharmaceutical care have a positive effect on the recovery of patients. In order to evaluate the clinical effectiveness and economic outcomes of clinical pharmaceutical care, relevant clinical trial studies were reviewed and analysed. METHODS: Two researchers searched literatures published from January 1992 to October 2019, and screened them by keywords like pharmaceutical care, pharmaceutical services, pharmacist interventions, outcomes, effects, impact, etc. Then, duplicate literatures were removed and the titles, abstracts and texts were read to screen literatures according to inclusion and exclusion criteria. Key data in the literature were extracted, and Meta-analysis was conducted using the literature with common outcome indicators. RESULTS: A total of 3299 articles were retrieved, and 42 studies were finally included. Twelve of them were used for meta-analysis. Among the 42 studies included, the main results of pharmaceutical care showed positive effects, 36 experimental groups were significantly better than the control group, and the remaining 6 studies showed mixed or no effects. Meta-analysis showed that clinical pharmacists had significant effects on reducing systolic blood pressure and diastolic blood pressure and shortening hospitalization days (P < 0.05), but no statistical significance in reducing medical costs (P > 0.05). CONCLUSION: Clinical pharmacists' pharmaceutical care has a significant positive effect on patients' clinical effects, but has no significant economic effect.


Assuntos
Assistência Farmacêutica/economia , Assistência Farmacêutica/normas , Serviço de Farmácia Hospitalar , Resultado do Tratamento , Assistência à Saúde , Feminino , Humanos , Masculino , Farmacêuticos , Papel Profissional
9.
Rev. cuba. salud pública ; 46(2): e1873, abr.-jun. 2020. tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1126865

RESUMO

Introducción: El seguimiento farmacoterapéutico es una de las actividades orientadas al paciente que debe desarrollar la farmacia comunitaria para disminuir la morbilidad y la mortalidad asociada al uso de medicamentos. Su implementación representa una oportunidad de optimizar la farmacoterapia y de mejorar la calidad de vida de los pacientes que reciban el servicio. Objetivo: Evaluar las condiciones básicas estructurales para la implementación del servicio de seguimiento farmacoterapéutico en las farmacias comunitarias de los municipios Diez de Octubre y Cerro de la provincia de La Habana. Métodos: Estudio descriptivo transversal realizado en el periodo de febrero-abril de 2016. Se evaluaron 44 farmacias comunitarias del municipio Diez de Octubre y 22 del municipio Cerro. Se empleó una guía de evaluación validada por expertos según Moriyama, que exploró cinco dimensiones y diez aspectos. Resultados: El municipio Cerro fue el menos favorable con menos dimensiones cumplidas. Para los dos municipios la dimensión de menor afectación fue la de recursos materiales y la de mayor la de servicios. Otras dimensiones afectadas fueron las de equipamiento, infraestructura y la de recursos humanos. La farmacia 710 de Diez de Octubre cumplió con la mayoría de las dimensiones evaluadas, excepto el acceso al Portal de la red Infomed. Conclusiones: Las farmacias comunitarias de los municipios Diez de Octubre y Cerro no tienen las condiciones básicas estructurales para implementar el servicio de seguimiento farmacoterapéutico(AU)


Introduction: Pharmacotherapy follow-up is one of the activities aimed to patients that must develop the community pharmacies to reduce morbidity and mortality associated to medications use. Its implementation represents an opportunity to optimize pharmacotherapy and to improve the quality of life for patients receiving the service. Objective: To evaluate the basic structural conditions for the implementation of the service of pharmacotherapy follow-up at the community pharmacies of 10 de Octubre and Cerro municipalities in Havana province. Methods: Descriptive cross-sectional study conducted in the period from February to April 2016. 44 community pharmacies were assessed in 10 de Octubre municipality and 22 in Cerro municipality. It was used a guide for the assessment validated by experts according to Moriyama, that explored five dimensions and ten aspects. Results: Cerro municipality was the least favourable with fewer dimensions accomplished. For both municipalities, the dimension with less affectation was the material resources and the one with greater affectation was services. Other affected dimensions were the equipment, infrastructure and human resources. The pharmacy #710 in 10 de Octubre municipality complied with most of the dimensions assessed, except for the access to INFOMED network´s web page. Conclusions: Community pharmacies of 10 de Octubre and Cerro municipalities do not have basic structural conditions to implement the service of pharmacotherapy follow-up(AU)


Assuntos
Humanos , Farmácias , Farmacêuticos , Assistência Farmacêutica/normas , Epidemiologia Descritiva , Estudos Transversais , Estudo Observacional
10.
Ann Hematol ; 99(7): 1615-1625, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32483668

RESUMO

Ibrutinib treatment has been shown to increase survival in patients with B cell malignancies. Real-life data suggest a large part of discontinuations are due to toxicities, impairing ibrutinib efficacy. We aimed to assess the impact of a pharmaceutical care program on the efficacy and safety of ibrutinib. This single-center, cohort, observational study enrolled patients with B cell malignancies. Patients were either assigned to the program or to receive usual care, based on physician decision. The program was conducted by clinical pharmacists specializing in oncology and included patient education for management of toxicities, adherence monitoring, interventions to reduce drug-drug interactions, and follow-up of transition from hospital to community. Between February 2014 and May 2017, we enrolled 155 patients, including 42 (27%) who were allocated to the program group and 113 (73%) to the usual care group. The effect of the program was beneficial in terms of time to treatment failure (p = 0.0005). The 30-month progression-free and overall survivals were significantly superior in the program group (respectively p = 0.002 and p = 0.004). Grade 3 or higher adverse events occurred more frequently for patients in the usual care group (15%) than program group (8%). A pharmaceutical care program provides a personalized environment for outpatient monitoring and control of the key risks associated with oral anticancer agents. This study shows evidence that management of ibrutinib treatment by clinical pharmacists results in significant improvement in survival and better tolerance than usual care.


Assuntos
Neoplasias/tratamento farmacológico , Neoplasias/mortalidade , Assistência Farmacêutica/normas , Pirazóis/uso terapêutico , Pirimidinas/uso terapêutico , Melhoria de Qualidade , Tempo para o Tratamento/normas , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Eficiência Organizacional , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Assistência Farmacêutica/organização & administração , Assistência Farmacêutica/tendências , Farmacêuticos/organização & administração , Farmacêuticos/normas , Análise de Sobrevida , Fatores de Tempo , Tempo para o Tratamento/organização & administração , Tempo para o Tratamento/tendências , Falha de Tratamento
11.
Pharm. pract. (Granada, Internet) ; 18(2): 0-0, abr.-jun. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-194057

RESUMO

BACKGROUND: Embedding pharmacists in general practice has been shown to create cost efficiencies, improve patient care and free general practitioner capacity. Consequently, there is a drive to recruit additional pharmacists to work within general practices. However, equipping pharmacists with behaviour and influencing skills may further optimise their impact. Key elements which may enhance behaviour and influencing skills include self-efficacy and resilience. OBJECTIVE: This study aimed to: 1) Assess general practice pharmacists' self-efficacy and resilience. 2) Explore differences primarily between pharmacists reporting lower and higher self-efficacy, secondarily for those reporting lower and higher scores for resilience. METHODS: All 159 NHS Greater Glasgow and Clyde general practice pharmacists were invited to complete an online survey in May 2019. The survey captured anonymised data covering: demographics; professional experience; qualifications, prescribing status and preferred learning styles. Unconscious learning needs for behavioural and influencing skills were assessed using validated tools: the new general self-efficacy scale (GSES) and short general resilience scale (GRIT). Participants' responses were differentiated by the lowest quartile and higher quartiles of GSES and GRIT scores, and analysed to identify differences. RESULTS: The survey was completed by 57% (91/159) of eligible pharmacists; mean age 38 (range 24-60) years; 91% were of white ethnicity and 89% female. The median time qualified was 14 (1-38) years and 3 (1-22) years working in general practices. Overall pharmacists scored well on the GSES, mean 25 (SD 3; 95%CI 24.4-25.6), and GRIT, mean 30 (SD 4; 95%CI 29.6-30.4), out of a maximum 32 and 40 respectively. A significant positive correlation between GSES and GRIT scores was found (Pearson's r=0.284, p = 0.006). However, no significant differences were identified between pharmacists scoring in the lower and upper quartiles by GSES or GRIT. Overall respondents reported their preferred learning styles were activists (46%) or pragmatists (29%). The majority (91%) preferred blended learning methods as opposed to 38% or less for a range of online methods. CONCLUSIONS: General practice pharmacists on average scored highly for self-efficacy and resilience. Higher scores did not appear to be associated with demographic, years of practice, professional or educational experience. Prospective interventions to support those with lower scores may enhance and optimise pharmacists' effectiveness in general practice


No disponible


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Determinação de Necessidades de Cuidados de Saúde , Serviços Comunitários de Farmácia , Educação em Farmácia , Autoeficácia , Competência Clínica , Assistência Farmacêutica/normas , Inquéritos e Questionários , Farmacêuticos/normas , Papel Profissional
12.
Pharm. pract. (Granada, Internet) ; 18(2): 0-0, abr.-jun. 2020.
Artigo em Inglês | IBECS | ID: ibc-194071

RESUMO

To address the changes in health care and the needs of society related to medicines, we must redefine the profession of pharmacy. We have defined the next generation pharmacists (NGP) as "a health care provider and change agent on the interprofessional health care team, personalizing medication use, managing safe and effective medication systems, and creating healthier communities." Schools and colleges of pharmacy should thoroughly examine their curriculum to ensure it is preparing pharmacists for this future. By creating a vision for the NGP and implementing the best curriculum, we ensure that pharmacists of the future will be up to the challenge of our society's health care needs


No disponible


Assuntos
Humanos , Farmacêuticos , Educação em Farmácia/métodos , Currículo/normas , Assistência Farmacêutica/normas , Comunicação Interdisciplinar , Educação em Farmácia/normas , Educação em Farmácia/tendências , Saúde Pública
15.
Ars pharm ; 61(1): 9-13, ene.-mar. 2020. ilus
Artigo em Espanhol | IBECS | ID: ibc-188569

RESUMO

El presente artículo es fruto de la conferencia dictada por la Dra. Carmen Peña en el acto de apertura del curso académico de la Cátedra María José Faus Dáder de Atención Farmacéutica, de la Universidad de Granada. En él se narra de manera secuencial el nacimiento y desarrollo de la Atención Farmacéutica en la que resulto esencial el papel que la Federación internacional de Farmacéuticos (FIP) ha jugado para su desarrollo. Conjuntamente con la OMS publican en 1999 el documento "Buenas Prácticas en Farmacia: Estándares para la calidad de los servicios farmacéuticos" que se ha seguido actualizando hasta su versión del 2011.En España, mientras el proceso de la Atención Farmacéutica (Pharmaceutical Care) a nivel mundial, tomaba velocidad de crucero, un grupo de líderes de la farmacia española se movilizó para introducirlos conceptos de la Declaración de Tokio 93, en relación con los principios de la Atención Farmacéutica. En el momento actual estos pioneros, entre los que se encuentran entre otros, el Consejo General de Farmacéuticos y la Cátedra de Atención Farmacéutica de la Universidad de Granada responsable de la integración del grupo de Atención Farmacéutica de dicha universidad, presentan una apuesta decidida por la farmacia profesional a través de una oferta de servicios farmacéuticos de calidad dirigidos al paciente


This article is based on the lecture given by Dr Carmen Peña at the start of the academic year of the María José Faus Dáder Chair of Pharmaceutical Care, of the University of Granada. It narrates the genesis and development of Pharmaceutical Care and the essential role played by the International Federation of Pharmacists (FIP) in its development. In 1999, FIP and WHO together published the document "Good Practices in Pharmacy: Standards for the Quality of Pharmaceutical Services" which has been updated continually until its 2011 version. In Spain, while the global development of Pharmaceutical Care was taking off, a group of Spanish pharmacy leaders mobilized to introduce the concepts of the Tokyo Declaration 93, in relation to the principles of Pharmaceutical Care. At the present time these pioneers, among whom are the General Council of Pharmacists and the Chair of Pharmaceutical Care of the University of Granada which is responsible for the integration of the Pharmaceutical Care group of said university, are firmly committed to Professional Pharmacy by way of offering quality pharmaceutical services aimed at the patient


Assuntos
Humanos , Assistência Farmacêutica/tendências , Farmácias/normas , Qualidade da Assistência à Saúde/organização & administração , Assistência Farmacêutica/organização & administração , Assistência Farmacêutica/normas , Qualidade da Assistência à Saúde/normas
16.
Int J Med Inform ; 136: 104092, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32062562

RESUMO

BACKGROUND AND PURPOSE: Patients' adherence to medication is a complex, multidimensional phenomenon. Dispensation data and electronic health records are used to approximate medication-taking through refill adherence. In-depth discussions on the adverse effects of data quality and computational differences are rare. The purpose of this article is to evaluate the impact of common pitfalls when computing medication adherence using electronic health records. PROCEDURES: We point out common pitfalls associated with the data and operationalization of adherence measures. We provide operational definitions of refill adherence and conduct experiments to determine the effect of the pitfalls on adherence estimations. We performed statistical significance testing on the impact of common pitfalls using a baseline scenario as reference. FINDINGS: Slight changes in definition can significantly skew refill adherence estimates. Pickup patterns cause significant disagreement between measures and the commonly used proportion of days covered. Common data related issues had a small but statistically significant (p < 0.05) impact on population-level and significant effect on individual cases. CONCLUSION: Data-related issues encountered in real-world administrative databases, which affect various operational definitions of refill adherence differently, can significantly skew refill adherence values, leading to false conclusions about adherence, particularly when estimating adherence for individuals.


Assuntos
Bases de Dados Factuais , Registros Eletrônicos de Saúde/estatística & dados numéricos , Adesão à Medicação/estatística & dados numéricos , Assistência Farmacêutica/estatística & dados numéricos , Assistência Farmacêutica/normas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Assistência Farmacêutica/tendências , Adulto Jovem
17.
Matern Child Health J ; 24(4): 439-446, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31953590

RESUMO

OBJECTIVES: The purpose of the current study was to describe anxious pregnant women's concerns about using pharmacotherapy to treat anxiety symptoms, and the relationship of such concerns to women's willingness to use pharmacotherapy during pregnancy. METHODS: Between April 2011 and May 2012, 148 women who were pregnant and reported elevated anxiety symptoms, as measured by the GAD-2, completed an online survey assessing their concerns about, and willingness to use, pharmacotherapy to treat anxiety symptoms during pregnancy. Qualitative responses were coded, and linear regression was used to assess the relationship between concerns and willingness. RESULTS: Pregnant women with elevated anxiety symptoms reported low willingness to use pharmacotherapy to treat anxiety symptoms during pregnancy. The most common concerns reported were about negative effects on the baby or the self, and a general opposition to taking any medications during pregnancy. These concerns were significantly related to women's willingness to try pharmacotherapy (ps < .016). CONCLUSION: Our findings underscore the importance of a pregnant woman's perceptions of potential side-effects and long-term effects of pharmacotherapy, both for herself and her offspring. These results point to specific factors that may be important to address in communication with patients about pharmacotherapy for anxiety disorders during pregnancy. Such an understanding may help clinicians provide more effective guidance and information about treatment options for anxiety disorders during pregnancy, and increase patients' willingness to engage in those treatments.


Assuntos
Ansiedade/tratamento farmacológico , Assistência Farmacêutica/normas , Gestantes/psicologia , Adulto , Ansiedade/psicologia , Feminino , Humanos , Assistência Farmacêutica/estatística & dados numéricos , Gravidez , Pesquisa Qualitativa , Inquéritos e Questionários
18.
Einstein (Sao Paulo) ; 18: eAO4858, 2020.
Artigo em Inglês, Português | MEDLINE | ID: mdl-31851225

RESUMO

OBJECTIVE: To develop and validate the content of a tool aimed to select patients with hypertension for pharmaceutical care, based on identification of individuals in greater need of attention. METHODS: The tool was developed and assessed for face and content validity, which was carried out in three stages. Phase I consisted of comprehensive literature review, which prompted the development of the first version of the tool. Phase II consisted of validation by an expert panel. Phase III consisted of a pilot study with hypertensive patients and preparation of the final version of the instrument. RESULTS: Literature review yielded 30 studies, out of which 13 factors associated with hypertension and cardiovascular disease control and complications were selected. Once the initial version of the tool named INSAF-HAS was obtained, four expert meetings were held, each leading to instrument improvement until a final consensus was reached. In the pilot study, INSAF-HAS was applied to 30 patients with a diagnosis of hypertension for applicability pretest; adjustments were made and the final version of INSAF-HAS obtained. CONCLUSION: The INSAF-HAS tool developed in this study has face and content validity, and may contribute to the selection of patients with hypertension in greater need of pharmaceutical care services.


Assuntos
Anti-Hipertensivos/uso terapêutico , Hipertensão/tratamento farmacológico , Seleção de Pacientes , Assistência Farmacêutica/normas , Inquéritos e Questionários/normas , Doenças Cardiovasculares/etiologia , Progressão da Doença , Feminino , Humanos , Hipertensão/complicações , Masculino , Projetos Piloto , Reprodutibilidade dos Testes , Fatores de Risco
20.
Goiânia; SES-GO; 2020. 31 p. ^eApêndicesilus.
Não convencional em Português | LILACS, Coleciona SUS, CONASS, SES-GO | ID: biblio-1117835

RESUMO

A criação deste material foi pautada na Lei de introdução às normas do Direito Brasileiro, que expressa, em seus artigos 20 a 22, que a decisão judicial sobre fornecimento de medicamentos e serviços de saúde deverá trazer fundamentação sobre as suas consequências práticas, considerando os obstáculos e as dificuldades reais do gestor e as exigências das políticas públicas, não podendo fundar-se apenas em valores jurídicos abstratos. E tem como objetivo apresentar os procedimentos administrativos de acesso à assistência no SUS, bem como apontar o ente federativo responsável


The creation of this material was based on the Law of introduction to the norms of Brazilian Law, which expresses, in articles 20 to 22, that the judicial decision on the supply of medicines and health services should bring reasons on its practical consequences, considering the obstacles and real difficulties of the manager and the requirements of public policies, and cannot be based only on abstract legal values. And it aims to present the administrative procedures of access to assistance in the SUS, as well as to point out the federative entity responsible.


Assuntos
Humanos , Assistência Farmacêutica/normas , Política Pública , Sistema Único de Saúde , Saúde Pública/normas , Judicialização da Saúde , Serviços de Saúde , Controle Social Formal , Transplante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA